NCT02268734View on ClinicalTrials.gov

Molecular Profile of Metastatic Sporadic Medullary Thyroid Cancer Patients and Correlation With Vandetanib

CompletedOBSERVATIONAL
Enrollment

36

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2018

Conditions
Metastatic Sporadic Medullary Thyroid Cancer
Trial Locations (1)

20133

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Milan

All Listed Sponsors
lead

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

OTHER

NCT02268734 - Molecular Profile of Metastatic Sporadic Medullary Thyroid Cancer Patients and Correlation With Vandetanib | Biotech Hunter | Biotech Hunter